title: Profile of placental alkaline phosphatase expression in human malignancies: effect of tumour cell activation on alkaline phosphatase expression.
abstract: Cellular alkaline phosphatases (ALP) are increasingly recognised as important markers for monitoring tumour cell behaviour in human malignancies. Colorimetric, flow-cytometric, and immunocytochemical assays were employed to assess the influence of activation on expression of cellular ALP in human tumour cell lines. The results showed the following: (1) Testis tumour biopsies (16/16) unlike bladder (0/14) and head and neck (0/16) tumours showed positive staining for ALP, particularly the placental type, i.e. PLAP, although this was not always present on all the cells of non-seminoma biopsies. (2) The intensity of ALP expression differed widely in tumour cell lines. Based on biochemical analysis, the profile of ALP fell into two categories: (a) low expressing (MW 70 kD, placental type ALP) like Hep2 and KB lines, and (b) those expressing both low and high molecular (MW 95 kD) bands like testis lines Tera II and Ep2102. In all cases treatment of tumour cell lysates with heat prior to biochemical analysis showed the disappearance of the higher and sharpening of the lower molecular weight ALP band. (3) Exposure of tumour cells to epidermal growth factor (EGF) expressing EGF receptor led to a decreased ALP expression by as much as 54% as assessed by biochemical or flow-cytometric techniques. These data demonstrated that testis tumour tissues and cell lines expressed ALP which were different from others. The data also showed that exposure of tumour cell lines expressing EGFr to EGF resulted in suppression of ALP expression. These observations are consistent with the notion that EGFr and PLAP expression may be taken as a marker of proliferation and differentiation in human malignancies, respectively.
authors.affiliation: Department of Medical Oncology, London Hospital Medical College and St. Bartholomew's Hospital, London, UK.
authors.forename: A A
authors.initials: AA
authors.lastname: Dabare
authors.forename: A M
authors.initials: AM
authors.lastname: Nouri
authors.forename: H
authors.initials: H
authors.lastname: Cannell
authors.forename: T
authors.initials: T
authors.lastname: Moss
authors.forename: A K
authors.initials: AK
authors.lastname: Nigam
authors.forename: R T
authors.initials: RT
authors.lastname: Oliver
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism*; D014408:Biomarkers, Tumor / Q000378:metabolism; D015153:Blotting, Western; D004586:Electrophoresis; D066246:ErbB Receptors / Q000378:metabolism*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D007124:Immunoenzyme Techniques; D007527:Isoenzymes / Q000378:metabolism; D007633:Keratins / Q000378:metabolism; D008297:Male; D013736:Testicular Neoplasms / Q000473:pathology; D014407:Tumor Cells, Cultured / Q000201:enzymology*
chemical_list: D014408:Biomarkers, Tumor; D007527:Isoenzymes; D007633:Keratins; D066246:ErbB Receptors; D000469:Alkaline Phosphatase